Neutral
Johnson & Johnson's OTTAVA Robotic Surgical System Receives FDA Authorization
In the past 24 hours, there have been no significant market-moving developments concerning Johnson & Johnson (JNJ). The company's stock closed at $268.19 on August 20, 2026, reflecting a 2.21% decrease from the previous day. Investors are awaiting upcoming events, including the release of the company's Q2 2026 earnings report and potential updates on the talc-related litigation settlement.
Key points
- No significant news affecting JNJ's stock in the past 24 hours.
- Stock closed at $268.19 on August 20, 2026, down 2.21%.
- Investors await Q2 2026 earnings report and talc litigation updates.
Sources
AI-generated from public news sources. Not financial advice.
